Haemonetics Corp (HAE) bonds
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)
Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –
Debt
Borrowings on the balance sheet, Jun 27, 2026
Total debt
$1.17B
$4.96M due within a year
Net debt
$950.77M
After $223.38M of cash
Implied interest rate
1.58%
FY2026 interest ÷ average debt
Interest coverage
8.1×
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Mar 28, 2026
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Haemonetics's 10-Q for the period ended Jun 27, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| Convertible Senior Notes Due 2029 Convertible at $117 a share | 2.50% | 2029 | $700.00M | $689.60M |
| 2024 Revised Credit Facilities | – | – | $250.00M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Revolving credit facility | – | $250.00M |
See a number that looks wrong?